These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 29067664

  • 1. PMO Delivery System Using Bubble Liposomes and Ultrasound Exposure for Duchenne Muscular Dystrophy Treatment.
    Negishi Y, Ishii Y, Nirasawa K, Sasaki E, Endo-Takahashi Y, Suzuki R, Maruyama K.
    Methods Mol Biol; 2018; 1687():185-192. PubMed ID: 29067664
    [Abstract] [Full Text] [Related]

  • 2. Bubble liposomes and ultrasound exposure improve localized morpholino oligomer delivery into the skeletal muscles of dystrophic mdx mice.
    Negishi Y, Ishii Y, Shiono H, Akiyama S, Sekine S, Kojima T, Mayama S, Kikuchi T, Hamano N, Endo-Takahashi Y, Suzuki R, Maruyama K, Aramaki Y.
    Mol Pharm; 2014 Mar 03; 11(3):1053-61. PubMed ID: 24433046
    [Abstract] [Full Text] [Related]

  • 3. Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy.
    Miyatake S, Mizobe Y, Takizawa H, Hara Y, Yokota T, Takeda S, Aoki Y.
    Methods Mol Biol; 2018 Mar 03; 1687():123-141. PubMed ID: 29067660
    [Abstract] [Full Text] [Related]

  • 4. Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.
    Echigoya Y, Lim KRQ, Trieu N, Bao B, Miskew Nichols B, Vila MC, Novak JS, Hara Y, Lee J, Touznik A, Mamchaoui K, Aoki Y, Takeda S, Nagaraju K, Mouly V, Maruyama R, Duddy W, Yokota T.
    Mol Ther; 2017 Nov 01; 25(11):2561-2572. PubMed ID: 28865998
    [Abstract] [Full Text] [Related]

  • 5. Antisense Oligonucleotide Treatment in a Humanized Mouse Model of Duchenne Muscular Dystrophy and Highly Sensitive Detection of Dystrophin Using Western Blotting.
    Maruyama R, Yokota T.
    Methods Mol Biol; 2021 Nov 01; 2224():203-214. PubMed ID: 33606217
    [Abstract] [Full Text] [Related]

  • 6. In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.
    Nakamura A, Aoki Y, Tsoumpra M, Yokota T, Takeda S.
    Methods Mol Biol; 2018 Nov 01; 1828():151-163. PubMed ID: 30171540
    [Abstract] [Full Text] [Related]

  • 7. Dosing regimen has a significant impact on the efficiency of morpholino oligomer-induced exon skipping in mdx mice.
    Malerba A, Thorogood FC, Dickson G, Graham IR.
    Hum Gene Ther; 2009 Sep 01; 20(9):955-65. PubMed ID: 19469709
    [Abstract] [Full Text] [Related]

  • 8. Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle.
    Novak JS, Hogarth MW, Boehler JF, Nearing M, Vila MC, Heredia R, Fiorillo AA, Zhang A, Hathout Y, Hoffman EP, Jaiswal JK, Nagaraju K, Cirak S, Partridge TA.
    Nat Commun; 2017 Oct 16; 8(1):941. PubMed ID: 29038471
    [Abstract] [Full Text] [Related]

  • 9. In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy.
    Wang Q, Yin H, Camelliti P, Betts C, Moulton H, Lee H, Saleh AF, Gait MJ, Wood MJ.
    J Gene Med; 2010 Apr 16; 12(4):354-64. PubMed ID: 20235089
    [Abstract] [Full Text] [Related]

  • 10. A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice.
    Yin H, Moulton HM, Betts C, Seow Y, Boutilier J, Iverson PL, Wood MJ.
    Hum Mol Genet; 2009 Nov 15; 18(22):4405-14. PubMed ID: 19692354
    [Abstract] [Full Text] [Related]

  • 11. In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.
    Heemskerk HA, de Winter CL, de Kimpe SJ, van Kuik-Romeijn P, Heuvelmans N, Platenburg GJ, van Ommen GJ, van Deutekom JC, Aartsma-Rus A.
    J Gene Med; 2009 Mar 15; 11(3):257-66. PubMed ID: 19140108
    [Abstract] [Full Text] [Related]

  • 12. Systemic Delivery of Morpholinos to Skip Multiple Exons in a Dog Model of Duchenne Muscular Dystrophy.
    Maruyama R, Echigoya Y, Caluseriu O, Aoki Y, Takeda S, Yokota T.
    Methods Mol Biol; 2017 Mar 15; 1565():201-213. PubMed ID: 28364245
    [Abstract] [Full Text] [Related]

  • 13. In Vivo Evaluation of Single-Exon and Multiexon Skipping in mdx52 Mice.
    Mizobe Y, Miyatake S, Takizawa H, Hara Y, Yokota T, Nakamura A, Takeda S, Aoki Y.
    Methods Mol Biol; 2018 Mar 15; 1828():275-292. PubMed ID: 30171548
    [Abstract] [Full Text] [Related]

  • 14. Designing Effective Antisense Oligonucleotides for Exon Skipping.
    Shimo T, Maruyama R, Yokota T.
    Methods Mol Biol; 2018 Mar 15; 1687():143-155. PubMed ID: 29067661
    [Abstract] [Full Text] [Related]

  • 15. Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse.
    Fletcher S, Honeyman K, Fall AM, Harding PL, Johnsen RD, Steinhaus JP, Moulton HM, Iversen PL, Wilton SD.
    Mol Ther; 2007 Sep 15; 15(9):1587-92. PubMed ID: 17579573
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy.
    Blain AM, Greally E, McClorey G, Manzano R, Betts CA, Godfrey C, O'Donovan L, Coursindel T, Gait MJ, Wood MJ, MacGowan GA, Straub VW.
    PLoS One; 2018 Sep 15; 13(6):e0198897. PubMed ID: 29912990
    [Abstract] [Full Text] [Related]

  • 19. Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene.
    Echigoya Y, Lim KRQ, Melo D, Bao B, Trieu N, Mizobe Y, Maruyama R, Mamchaoui K, Tanihata J, Aoki Y, Takeda S, Mouly V, Duddy W, Yokota T.
    Mol Ther; 2019 Nov 06; 27(11):2005-2017. PubMed ID: 31416775
    [Abstract] [Full Text] [Related]

  • 20. Morpholino-induced exon skipping stimulates cell-mediated and humoral responses to dystrophin in mdx mice.
    Vila MC, Novak JS, Benny Klimek M, Li N, Morales M, Fritz AG, Edwards K, Boehler JF, Hogarth MW, Kinder TB, Zhang A, Mazala D, Fiorillo AA, Douglas B, Chen YW, van den Anker J, Lu QL, Hathout Y, Hoffman EP, Partridge TA, Nagaraju K.
    J Pathol; 2019 Jul 06; 248(3):339-351. PubMed ID: 30883742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.